NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054546

Registered date:02/06/2024

Circulating Tumor DNA for Predicting Occult Metastases in Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedResectable and borderline resectable pancreatic ductal adenocarcinoma
Date of first enrollment2019/05/01
Target sample size130
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeAssociation of preoperative ctDNA and occult metastases
Secondary OutcomeAssociation of preoperative ctDNA and prognosis

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximum85years-old
GenderMale and Female
Include criteria
Exclude criteria1) Patients with pathologically carcinoma in situ or complete response by neoadjuvant therapy 2) Patients with active cancer

Related Information

Contact

public contact
Name Takeshi Murakami
Address South 1, West 16, Chuo-ku, Sapporo, Hokkaido 060-0061, Japan Japan 060-8556
Telephone 0116112111
E-mail murakami.takeshi@sapmed.ac.jp
Affiliation Sapporo Medical University Department of Surgery, Surgical Oncology and Science
scientific contact
Name Takeshi Murakami
Address South 1, West 16, Chuo-ku, Sapporo, Hokkaido 060-0061, Japan Japan
Telephone 0116112111
E-mail murakami.takeshi@sapmed.ac.jp
Affiliation Sapporo Medical University Department of Surgery, Surgical Oncology and Science